美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
0071-5212-23	0071-5212	HUMAN PRESCRIPTION DRUG	ACCURETIC	quinapril and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20211206	N/A	NDA	NDA020125	Parke-Davis Div of Pfizer Inc	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5 mg/1; 20 mg/1	90 TABLET, FILM COATED in 1 BOTTLE (0071-5212-23)
0071-3112-23	0071-3112	HUMAN PRESCRIPTION DRUG	ACCURETIC	quinapril and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20211129	N/A	NDA	NDA020125	Parke-Davis Div of Pfizer Inc	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5 mg/1; 10 mg/1	90 TABLET, FILM COATED in 1 BOTTLE (0071-3112-23)
59762-0222-1	59762-0222	HUMAN PRESCRIPTION DRUG	quinapril hydrochloride and hydrochlorothiazide	quinapril hydrochloride and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19991228	N/A	NDA AUTHORIZED GENERIC	NDA020125	Greenstone LLC	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5 mg/1; 10 mg/1	90 TABLET, FILM COATED in 1 BOTTLE (59762-0222-1)
59762-0220-1	59762-0220	HUMAN PRESCRIPTION DRUG	quinapril hydrochloride and hydrochlorothiazide	quinapril hydrochloride and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19991228	N/A	NDA AUTHORIZED GENERIC	NDA020125	Greenstone LLC	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5 mg/1; 20 mg/1	90 TABLET, FILM COATED in 1 BOTTLE (59762-0220-1)
59762-0223-1	59762-0223	HUMAN PRESCRIPTION DRUG	quinapril hydrochloride and hydrochlorothiazide	quinapril hydrochloride and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19991228	N/A	NDA AUTHORIZED GENERIC	NDA020125	Greenstone LLC	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	25 mg/1; 20 mg/1	90 TABLET, FILM COATED in 1 BOTTLE (59762-0223-1)
59762-5225-9	59762-5225	HUMAN PRESCRIPTION DRUG	quinapril and hydrochlorothiazide	quinapril and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20211025	N/A	NDA AUTHORIZED GENERIC	NDA020125	Greenstone LLC	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	25 mg/1; 20 mg/1	90 TABLET, FILM COATED in 1 BOTTLE (59762-5225-9)